Biowise Capital II, LLC — Form D/A
Biowise Capital II, LLC of DALLAS, TX, a pooled investment fund, filed a Form D amendment with the SEC on 2023-11-15. The offering totals $10.0M, of which $1.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-11-15
- Form: D/A
- Accession: 0001999472-23-000002
- Industry: Biotechnology
- Exemptions: 06c, 3C, 3C.1
- Total offering: $10.0M
- Amount sold: $1.1M
- Remaining: $8.9M
- Minimum investment: $50K
- Investors: 14
- Date of first sale: 2021-03-01
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-388670
Issuer
- Name: Biowise Capital II, LLC
- CIK: 0001844785
- Entity type: Limited Liability Company
- Jurisdiction: TEXAS
- Incorporated: 2020
- Address: 100 CRESCENT COURT,, DALLAS, TX, 75201
- Phone: 214-810-4339
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| Amir Baluch | Executive Officer | Dallas, TX |
Other filings by this issuer (1)
More